Clinical trial
A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
NCT01400971 is registered in ClinicalTrials.gov with Eli Lilly and Company as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multinational Observational Study Assessing Insulin Use: Understanding the Challenges Associated With Progression of Therapy - The MOSAIc Type 2 Diabetes Study
- Lead sponsor
- Eli Lilly and Company
- Phase
- Observational
- Overall status
- Completed
- Start date
- July 31, 2011
- Completion date
- September 30, 2015
- Enrollment
- 4,299 (actual)
- Sites
- 153
Conditions
As the registry lists them; a condition with its own page is linked.